ライフサイエンスコーパス: biosensing

1 ns of these Ab-AuNP bioconjugates in optical biosensing.

2 ity reagents for cell labelling, imaging and biosensing.

3 cluding quantum optics, optoelectronics, and biosensing.

4 um technologies, nanoscale magnetometry, and biosensing.

5 hitectures and their multitasking ability in biosensing.

6 ing fields of bioenergy, bioremediation, and biosensing.

7 vestigations on its potential application in biosensing.

8 ioconjugates are widely used in the field of biosensing.

9 range of sensing applications, predominantly biosensing.

10 neration of useful probes for bioimaging and biosensing.

11 rated with a high-performance transistor for biosensing.

12 a new device for electrochemical sensing and biosensing.

13 ics, and demonstrate virus-lasing probes for biosensing.

14 ectable by standard microfluidic systems for biosensing.

15 mportant advantage for advanced nucleic acid biosensing.

16 terials essential for robust, ultrasensitive biosensing.

17 ty studies, immunogold labelling and in vivo biosensing.

18 onics, silicon photonics, photovoltaics, and biosensing.

19 ned criteria toward wearable textile glucose biosensing.

20 into MNAs and their effectiveness for dermal biosensing.

21 their potential applications for sensing and biosensing.

22 sis, electronics, nanomaterial synthesis and biosensing.

23 ause disruptive improvements in the field of biosensing.

24 th special interest on in situ catalysts and biosensing.

25 oli detection is unprecedented in label-free biosensing.

26 up diverse possibilities for (19) F MR based biosensing.

27 treatment, bioremediation, desalination, and biosensing.

28 , chiral polarizers, and colorimetric chiral biosensing.

29 ation of ILs and MIPs for biorecognition and biosensing.

30 nt FRET donor that supports red/far-red FRET biosensing.

31 n optoelectronics but also in bioimaging and biosensing.

32 and reusability when used for solution-phase biosensing.

33 ic adsorption, a major issue in the field of biosensing.

34 cence for use in fluorescence bioimaging and biosensing, a high loading capacity of aromatic compound

35 This paper presents a review of EIS biosensing advancements and introduces different detecti

36 te our approach in the context of label-free biosensing and achieve ultrasensitive and perceptually e

37 iotechnology applications, including optical biosensing and delivery.

38 ration optical sensors for online and remote biosensing and device applications.

39 pment of nanostructures for integrating into biosensing and devices for a broad field of applications

40 plications, including drug delivery systems, biosensing and electrical modulation of tissues and orga

41 ge of metals which can be used for plasmonic biosensing and increases the sensitivity by 3-4 orders o

42 chitectures, which can be used for sensitive biosensing and on-chip optical information processing.

43 NA biosensors that have utility in lab-based biosensing and potential for disease diagnostics.

44 summarizes the latest trends in the field of biosensing and provides an update on the current challen

45 zation effect and the development of quantum biosensing and quantum storage devices are discussed.

46 malism is articulated before examining their biosensing and related ET utility.

47 ely developed and manufactured for potential biosensing and theranostic applications while lacking co

48 s in diverse fields, including biocatalysis, biosensing, and chemical weapons defense.

49 -have become powerful tools in chemical- and biosensing, and have achieved notable success in portabl

50 hich can be exploited in various biomedical, biosensing, and materials fields.

51 hysiology, tissue engineering, drug release, biosensing, and molecular bioelectronics, is discussed.

52 oward the application of GQDs in bioimaging, biosensing, and therapy is reviewed, along with a discus

53 imodal imaging, theranostics, drug delivery, biosensing, and tissue engineering.

54 ively separates the cathode display from the biosensing anode, protecting it from the sample.

55 um dioxide (TiO(2)) is a unique material for biosensing applications due to its capability of hosting

56 channel-based membranes for nanofluidics and biosensing applications have been developed to regulate

57 PR wavelength, the signal-to-noise ratio for biosensing applications obtained using the proposed meth

58 end the discussion on the recent progress in biosensing applications of the produced MoS(2), highligh

59 ion on the graphene surface are critical for biosensing applications of these biosensors fabricated w

60 rase reaction is widely employed for several biosensing applications where bacterial ATP detection al

61 easy-to-understand examples of NHA-based POC biosensing applications, its current status, challenges,

62 om in the use of peroxidase gold nanozyme in biosensing applications.

63 nts with biomolecules (i.e., antibodies) for biosensing applications.

64 ufacturing gold electroplating processes for biosensing applications.

65 c nanocomposites are promising catalysts for biosensing applications.

66 e system can have widespread applications in biosensing applications.

67 unctionalized transition metal nanosheets in biosensing applications.

68 construction of the novel biointerfaces for biosensing applications.

69 ydroxyl group was not investigated at all in biosensing applications.

70 roves multilayer sensitivity of detection in biosensing applications.

71 how these properties could be exploited for biosensing applications.

72 The biosensing approach implied the use of ITO electrode coa

73 This unconventional biosensing approach involves measuring the change in sam

74 Importantly, our liquid biopsy-based biosensing approach is capable of differentiating health

75 ating characteristic analysis shows that our biosensing approach is highly specific, with an area und

76 e present a new capillary-based microfluidic biosensing approach to easily and reliably capture ~500

77 In general, biosensing approaches are based on measuring signals res

78 Recent advanced developments in biosensing approaches for cancer biomarker owes much cre

79 erature that techniques such as field effect biosensing are capable of rapid and flexible biological

80 echnique for multiplexed and high-throughput biosensing are discussed.

81 their applications in the biorecognition and biosensing are proposed.

82 he state-of-art strategies of PN hybrids for biosensing are summarized from the view of the role of n

83 e promising applications of nanozymes in the biosensing area.

84 rent state programmability for calibrating a biosensing array to render a homogeneous response across

85 ry, field-effect transistors, affinity-based biosensing, as well as biofuel cells.

86 Herein, we built a SPRi biosensing assay for high-sensitive and multiplex charac

87 ems as well as the complexity of designing a biosensing assay for long-term and real-time measurement

88 Besides, the developed biosensing assay was successfully applied in the determi

89 as an efficient platform in construction of biosensing assays.

90 rGO thin films opens promising prospects for biosensing beyond the Debye-screening limitation, which

91 OEs also offer a novel molecular approach to biosensing, bioimaging, and disease therapy.

92 ilitate the development of DNA nanomachines, biosensing/bioimaging, drug delivery, etc.

93 ications of FNA-nanomaterials in bioimaging, biosensing, biomedicine, and other important fields, wit

94 ications of FNA nanomaterials in bioimaging, biosensing, biomedicine, and other important fields, wit

95 immobilized enzymes underpins development of biosensing, bioprocessing, and analytical chemistry tool

96 various cellular applications in imaging and biosensing, but their functions as precise regulators in

97 Thus, pH biosensing by TGN PI4P allows for direct metabolic regul

98 pH biosensing by TGN PI4P in response to nutrient availabil

99 platforms maneuvers their outcoming optical biosensing capabilities.

100 provide results demonstrating improvement in biosensing capability.

101 e further applied in analytical separations, biosensing, cell studies, and drug-related studies.

102 nt scientific progress in using impedimetric biosensing combined with RTILs for the development of se

103 eposited onto electrode surface and a robust biosensing complex film with porous network structure wa

104 mance and the compact integration of various biosensing components with/in miniaturized and portable

105 ations of cellular homeostasis and that this biosensing concept is able to discriminate analytes with

106 We demonstrate a new biosensing concept with impact on the development of rap

107 For biosensing, CPs offer new possibilities to incorporate b

108 For example, DA biosensing designs generalize across DNA and RNA aptamer

109 ith, and exciting prospects of, CRISPR based biosensing developments are discussed.

110 In this work we discuss a new label-free biosensing device based on indium tin oxide (ITO) overla

111 with limit of detection of 330 +/- 70 aM The biosensing device consists of an array of gold nano-ante

112 e-step printing process for fabrication of a biosensing device developed keeps in mind the growing ne

113 ribes a novel and disruptive electrochemical biosensing device that is self-powered by light and self

114 The new biosensing device was applied to quality control analysi

115 bove-mentioned requirements for a successful biosensing device.

116 Finally, both commercial in vitro biosensing devices and recent state-of-art techniques fo

117 le, precise, and safe delivery of diagnostic biosensing devices and therapeutic agents to the target

118 , we critically discuss the state-of-the-art biosensing devices for COVID-19 testing.

119 A new approach to biosensing devices is demonstrated aiming an easier and

120 rategies but the key essential features that biosensing devices require are: (1) sensitivity, (2) sel

121 as an example of portable, rapid, and smart biosensing devices widely used for qualitative and quant

122 of ultrasensitive label-free and reagentless biosensing devices, particularly for point-of-care clini

123 ll as in the development of various types of biosensing devices.

124 loited widely for many applications, such as biosensing, disease diagnosis and therapy, bioimaging, a

125 tatus that cannot be ignored in the field of biosensing due to the excellent biocompatibility and fle

126 anomaterials, have played essential roles in biosensing due to their intrinsic magnetic, electrochemi

127 operties are integrated to achieve selective biosensing, efficient energy conversion, and the product

128 Traditional electrochemical biosensing electrodes (e.g., gold disk, glassy carbon el

129 A biosensing event occurred when a hairpin target probe re

130 In this biosensing feature, the detection is based on the covale

131 gies for GFAP, among the most popular in the biosensing field and never examined side by side within

132 duction technique with a leading role in the biosensing field due to its high sensitivity and low bac

133 The alcohol-oxidase (AOx) biosensing fluidic system allowed real-time tear collect

134 a new gateway for next generation selective biosensing for biomedical research applications.

135 d on the literature update of smart using of biosensing for detection of mycotoxin at both academic a

136 nostructures for electrochemical and optical biosensing for disease-specific biomarkers.

137 tlook on the future of DNA nanotechnology in biosensing for microRNA and beyond.

138 wever, current CRISPR-Cas-based nucleic acid biosensing has a lack of the quantitative detection abil

139 Plasmonic biosensing has emerged as the most sensitive label-free

140 bioreceptor immobilization and amperometric biosensing in a microfluidic platform.

141 such as regenerative repair in medicine and biosensing in bioengineering.

142 By developing fluorescent protein biosensing in intact seeds, we observed ATP accumulation

143 This enables spatially resolved biosensing in large area (approximately centimeters squa

144 omplex colloids represent a new approach for biosensing in liquid environments.

145 hybrids) have been designed and applied for biosensing in recent years.

146 fluidic technologies offer new platforms for biosensing in various clinical and point-of-care (POC) a

147 We have demonstrated stable, dose dependent biosensing in varying salivary pH's.

148 dye's use for amyloid fibrils bioimaging and biosensing in vivo.

149 icial for biomedical applications, including biosensing, in vivo imaging, and drug and gene delivery.

150 also have attractive properties for in vitro biosensing, including brightness(2), low cost(3) and sel

151 Currently, the development of biosensing instruments attracted important attention bec

152 nts, quality control of foods and beverages, biosensing intracellularly, identification of bacteria a

153 nergy between proteins and nanomaterials for biosensing is emphasized and discussed.

154 Affinity biosensing is leveraged for THC biomarker detection thro

155 electrode for HT-2 mycotoxin immunoenzymatic biosensing is reported.

156 scopy (SERS), with extensive applications in biosensing, is demonstrated to be particularly promising

157 The prepared biosensing layer (MGNR/BA/Ab) with well-oriented antibod

158 Then, the biosensing layer was magnetically collected on a screen-

159 The biosensing mechanism associated with nanotechnology-assi

160 The biosensing mechanism offers a fast and label-free approa

161 rformance and usability of diagnostic tools, biosensing mechanisms based on electrochemical impedance

162 A rapid and ultrasensitive biosensing method based on fiber optic nanogold-linked i

163 We present a biosensing method capable of appraising, on a short time

164 s, we have developed a low-cost photothermal biosensing method for the quantitative genetic detection

165 e critically review in depth newly developed biosensing methods especially for in-field and point-of-

166 The biosensing methods overcome these drawbacks, as these ar

167 A combination of multiplexed biosensing, microfluidic sampling and transport systems

168 Finally, biosensing microneedle patches associated with personali

169 ications, such as targeted delivery, in vivo biosensing, minimally invasive surgery and cell manipula

170 study, utilizing a novel magnetic modulation biosensing (MMB) system and the Zika nonstructural 1 pro

171 ease are driving the development of low-cost biosensing modalities, such as label-free photonic metho

172 We study wrapping methods dependent optical biosensing modulation by insulin and platelet-derived gr

173 Although luminescent biosensing nanoprobes have been developed to address thi

174 Advancing biosensing nanotechnologies in chemically "noisy" bioenv

175 r potential for application in therapeutics, biosensing, nanotechnology, and biocomputing.

176 n in organic transistors has led to enhanced biosensing, neuromorphic function, and specialized circu

177 , the device has been applied for label-free biosensing of avidin in both the domains simultaneously.

178 oof-of-concept application, highly sensitive biosensing of butyrylcholinesterase (BChE) activity usin

179 nt trends in the electrochemical sensing and biosensing of DNA methylation.

180 he as-synthesized composites were tested for biosensing of hydrogen peroxide (H2O2) and as supercapac

181 thermal agent, was used for the photothermal biosensing of MTB DNA under 808 nm laser irradiation.

182 f neurotransmitters, the developed NIR-based biosensing of neurotransmitters in stem cell-derived neu

183 However, the method to improve EIS biosensing on muPADs is less explored.

184 romising technologies in many fields such as biosensing, optical monitoring, and portable devices.

185 designed gate may be applied in biomedicine, biosensing or for building synthetic cells.

186 In addition to accurate biosensing, our gratings inherently enable force-sensing

187 ological advances in electrochemical glucose biosensing over the past decade (2010-present), along wi

188 eedles, the requirements from the integrated biosensing part are quite special compared to static glu

189 a new platform for surface plasmon resonance biosensing, paving the way for compact biosensors for po

190 age of siRNA while also carrying a synthetic biosensing peptide on the surface that is cleaved into a

191 s of layer-by-layer assembly with functional biosensing peptides to create a new class of nanotherano

192 Biosensing performance was optimized by varying the gap

193 easibility of Lab-on-PCB patches in terms of biosensing performance, paving the way for the first cos

194 urements yielded significant improvements in biosensing performances, including the limit of detectio

195 A miniature biosensing platform based on MgO-based nanoparticle dope

196 The proposed biosensing platform could be multiplexed and can be used

197 lance (QCM) systems have emerged as a robust biosensing platform due to their label-free mechanism, w

198 s alumina membranes have become a ubiquitous biosensing platform for a variety of applications and ap

199 sor for the first time and it offered a good biosensing platform for anti-IL 1alpha antibody immobili

200 This work presents an impedimetric biosensing platform for following and detecting sialylat

201 ductive carbon fiber to construct a flexible biosensing platform for monitoring biomarkers in sweat.

202 sation and graphene to fabricate an enhanced biosensing platform for the detection of motile bacteria

203 ology for the realization of a point-of-care biosensing platform for the detection of multiple brain-

204 The biosensing platform is comprised of photo-active NiWO(4)

205 The biosensing platform is created by 3D nanoprinting of thr

206 The resulting highly transformative biosensing platform operates with different photolumines

207 nts and b) effect of sample flow rate on the biosensing platform performance.

208 We demonstrate a swarm biosensing platform that detects analyte based on the ch

209 An advanced nanomaterial-based biosensing platform that detects COVID-19 antibodies wit

210 Besides, this biosensing platform was demonstrated to operate with rea

211 We exploit this to generate a biosensing platform with a limit of detection of 3 nM an

212 A novel and robust enzymatic biosensing platform with high sensitivity is developed b

213 the use as molecular recognition elements in biosensing platform.

214 printing on a PCB-integrated electrochemical biosensing platform.

215 luation, aiming for practical application in biosensing platform.

216 ation of the THC immobilization assay on the biosensing platform.

217 Use of nanomaterials offers to biosensing platforms exceptional optical, electronic and

218 ists and academics to design and develop new biosensing platforms for point-of-care (POC) diagnostics

219 we reviewed advancements in electrochemical biosensing platforms towards the detection of SARS-CoV-2

220 awn lots of attention for the development of biosensing platforms.

221 with RTILs for the development of sensitive biosensing platforms.

222 ears, due to their potential applications in biosensing, polarization-encoded optical communication,

223 Based on the exceptional and new opened biosensing possibilities of self-propelled micromotors,

224 This work demonstrates the high biosensing potential of flexible polymeric SAW devices f

225 also the implementation of the photothermal biosensing principle in a lab-on-a-chip format.

226 the first attempt to apply the photothermal biosensing principle in portable PMMA/paper-based analyt

227 The photothermal biosensing principle is of increasing interest for point

228 The fabrication of the biosensing probe was characterized using DIC, Fourier tr

229 each of them focuses on a key aspect of the biosensing process.

230 in interdigital micro-electrode systems for biosensing processes.

231 n enormous and largely untapped reservoir of biosensing proteins.

232 analysis/sensing system, and newly developed biosensing prototypes having commercial viability.

233 to be an excellent platform for sensing and biosensing purposes.

234 vantage of molecular imprinting, but not for biosensing purposes.

235 ible, and economical recognition elements in biosensing/quantification devices for CRISPR/Cas9 RNP.

236 uitable hydrophilic interface for an aqueous biosensing reaction, confirmed by water contact angle me

237 utline our recommendations on biosensors and biosensing-related issues towards pandemic outbreaks.

238 eneral guidelines both for scientists in the biosensing research community and for the biosensor indu

239 As biosensing research is rapidly advancing due to signific

240 Importantly, the biosensing response can be interrogated in real time.

241 Biosensing responses were confirmed by immunohistochemis

242 dvances achieved for various LDG sensing and biosensing schemes and their applications in the fields

243 re, potentially enabling new capabilities in biosensing, sequencing, and imaging.

244 l of using the memristor to directly process biosensing signals is also demonstrated.

245 arnessed in a wide range of areas, including biosensing, single-molecule chemistry, and single-molecu

246 ent cutting-edge research on electrochemical biosensing strategies are described.

247 r of very recently developed electrochemical biosensing strategies are promoting electrochemical bios

248 Therefore development of new biosensing strategies for detection of UV-induced DNA da

249 Next, the CRISPR based biosensing strategies for nucleic acids, proteins and sm

250 there is a continuing interest in different biosensing strategies that allow for the point-of-care m

251 ecific analyte to the development of general biosensing strategies that can be applied for a single c

252 old peroxidase (Auperoxidase) nanozyme based biosensing strategies, it is apt to meticulously review

253 e assessed the analytical performance of the biosensing strategy by using clinical samples of Ebola v

254 ur knowledge, this is the first photothermal biosensing strategy for quantitative nucleic acid analys

255 This SPRi biosensing strategy might offer a potential alternative

256 on of a clip-magazine-assembled photothermal biosensing strategy.

257 Third, examples of current biosensing structures created from hybrid nanomaterials

258 ys to deployment of a complete point-of-care biosensing system in a clinical setting.

259 this work, we demonstrated the benchtop GMR biosensing system in the context of ovarian cancer assay

260 n a 3D printed chip to create a microfluidic biosensing system that is genuinely portable.

261 nts into the self-powered and self-signalled biosensing system that merges photovoltaic cells, plasti

262 s study is focused on developing a selective biosensing system using iron nanoflorets graphene nickel

263 nd fluorescent probes, respectively, in this biosensing system.

264 ate the progress in the development of novel biosensing systems and biosensors for the detection of t

265 omaterials have been extensively utilized in biosensing systems for highly sensitive and selective de

266 ing strategies are promoting electrochemical biosensing systems into practical point-of-care applicat

267 chemical and physical properties in the ECL biosensing systems is one of the most interesting resear

268 s are being made to design and develop novel biosensing systems of reduced form factor and high perfo

269 op and handheld Giant Magnetoresistive (GMR) biosensing systems that serve as platforms for detecting

270 advance algorithm developments for cortisol biosensing systems to mitigate stress-based illnesses an

271 t of high-performance molecular beacon-based biosensing systems.

272 ystem can be utilized for the development of biosensing systems.

273 ents and paving the way to future integrated biosensing systems.

274 ly developed thermal mediated immunochemical biosensing technique which involves the binding of speci

275 Despite the recent advances in biosensing techniques for monitoring spatiotemporal cAMP

276 and target specificity to be implemented in biosensing techniques.

277 To reduce this burden, biosensing technologies are emerging that provide feedba

278 ses on describing the known and emerging CVD biosensing technologies for analysis of cardiac biomarke

279 gold nanomaterials are central to many novel biosensing technologies for example the lateral flow ass

280 ng of enzymes, development of more efficient biosensing technologies, and constructing novel biomimet

281 In that regard, wearable biosensing technologies, capable of tracking drug pharma

282 interactions, further driving innovations in biosensing technologies.

283 State-of-art biosensing technology is the least component-based and t

284 advancements have been made in the field of biosensing technology.

285 xide (Tyr/ZnO-rGO) nanocomposite system as a biosensing test-bed for rapid and sensitive detection of

286 nd functional assays to identify and isolate biosensing TFs, and a quantum-dot Forster Resonance Ener

287 ratings (TFBGs) functionalized for D-glucose biosensing through polydopamine (PDA)-immobilized concan

288 Biosensing through White Light Reflectance Spectroscopy

289 have broad applications from single-molecule biosensing to diagnostics and sequencing.

290 ed review, we underscore the crucial role of biosensing to handle with such situations.

291 EIS as a biosensing tool allows detection of a broad range of tar

292 DSSC), in which one of the electrodes is the biosensing unit.

293 In the field of label-free biosensing, various transducer materials and strategies

294 Real-time impedance biosensing verified in vitro early, dose-dependent quant

295 lls, but the utility of the red spectrum for biosensing was limited due to a lack of bright and stabl

296 e the suitability of Hexaammineruthenium for biosensing we applied it for the impedimetric detection

297 oint-of-care diagnostics or cellular in vivo biosensing when using ultrathin fiber optic probes for r

298 ng of surface plasmon resonance (SPR) immuno-biosensing with ambient ionization mass spectrometry (MS

299 ng for being applied in photoelectrochemical biosensing with high photo-electron conversion efficienc

300 translation systems have great potential for biosensing, yet the range of detectable chemicals is lim